Pediatric ID News

When it comes to screening perinatally exposed infants for hepatitis C virus, the earlier the better, a study showed.

SAN ANTONIO — We caught up with Connie Steed, MSN, RN, CIC, FAPIC, at the annual meeting of the Association for Professionals in Infection Control and Epidemiology to find out how she got “Hooked on ID.”

Lenacapavir, an injectable antiretroviral drug approved by the FDA for HIV treatment, prevented 100% of new HIV infections among women in a phase 3 trial in Africa, demonstrating its efficacy as PrEP, Gilead Sciences said.

We checked in with CDC Director Mandy K. Cohen, MD, MPH, for an update on the agency’s efforts to modernize the nation’s disease surveillance and data systems and improve how the CDC communicates with the public and physicians.

Urinalysis did not accurately diagnose UTIs in children with spina bifida, according to study results published in Pediatrics.

COVID-19 mitigation measures disrupted the circulation of respiratory syncytial virus, leading to atypical season in 2021 and 2022 that saw higher rates of hospitalization among young children, according to research published in Pediatrics.

In late May, the FDA announced approval of Moderna's mResvia, marking the third vaccine approved for respiratory syncytial virus and first time messenger RNA technology has been used for preventing a disease other than COVID-19.

Children in Massachusetts who were publicly insured or living in less affluent ZIP codes were less likely to receive nirsevimab, a monoclonal antibody for respiratory syncytial virus, according to research published in Pediatrics.

Many immigrant communities are at risk for outbreaks of vaccine-preventable diseases because of low and declining vaccination coverage, according to findings published in Pediatrics.

The geographic range of ticks in the United States is expanding, which may place more people than ever at risk for tick-borne diseases. We asked Richard S. Ostfeld, PhD, for an explanation.